Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 3/20 | 0.77 |
| ▸ | HTR1A | P08908 | 2/20 | 0.77 |
| ▸ | HTR1D | P28221 | 1/20 | 0.77 |
| ▸ | DRD2 | P14416 | 1/20 | 0.67 |
| ▸ | DRD4 | P21917 | 1/20 | 0.67 |
| ▸ | HTR1E | P28566 | 1/20 | 0.67 |
| ▸ | HTR7 | P34969 | 1/20 | 0.67 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.67 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | HTR1F | P30939 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2356044 | 1.00 | HTR1B (0.77) | HTR1BHTR1AHTR1DDRD2DRD4 | |
| SCHEMBL3791546 | 1.00 | HTR1B (0.77) | HTR1BHTR1AHTR1DDRD2DRD4 | |
| Bromide SCHEMBL9270717 | 0.99 | HTR1B (0.76) | HTR1BHTR1AHTR1DDRD2DRD4 | |
| Hydrochloric Acid SCHEMBL7744322 | 0.99 | HTR1B (0.76) | HTR1BHTR1AHTR1DDRD2DRD4 | |
| SCHEMBL9260550 | 0.96 | HTR1B (0.71) | HTR1BHTR1AHTR1DDRD2DRD4 | |
| Succinic Acid SCHEMBL7109541 | 0.94 | HTR1B (0.78) | HTR1BHTR1AHTR1DDRD2DRD4 | |
| Succinic Acid SCHEMBL7748928 | 0.94 | HTR1B (0.78) | HTR1BHTR1AHTR1DDRD2DRD4 | |
| Succinic Acid SCHEMBL3801747 | 0.93 | HTR1B (0.80) | HTR1BHTR1AHTR1DDRD2DRD4 | |
| SCHEMBL9333527 | 0.89 | HTR1B (0.61) | HTR1BHTR1AHTR1DDRD2DRD4 | |
| Pidolic Acid SCHEMBL9270714 | 0.88 | HTR1B (0.62) | HTR1BHTR1AHTR1DDRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1104292-A2 | TREATMENT OF VASODILATORY HEADACHE | Vernalis Limited (GB) | 2001-06-06 | — | — | EP | claimed |
| WO-2000009099-A2 | TREATMENT OF VASODILATORY HEADACHE | VERNALIS LIMITED (GB) | 2000-02-24 | — | — | WO | claimed |
| WO-1999022730-A1 | USE OF (+)-6-CARBOXAMIDO-3-METHYLAMINO-1,2,3,4-TETRAHYDROCARBAZOLE FOR TREATING HYPERALGESIA | VANGUARD MEDICA LIMITED (GB) | 1999-05-14 | — | — | WO | claimed |
| EP-0674621-A1 | ENANTIOMERS OF CARBAZOLE DERIVATIVES AS 5-HT1-LIKE AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1995-10-04 | — | — | EP | claimed |
| WO-1994014772-A1 | ENANTIOMERS OF CARBAZOLE DERIVATIVES AS 5-HT1-LIKE AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1994-07-07 | — | — | WO | claimed |
| EP-0591280-A1 | USE OF TETRAHYDROCARBAZOLE DERIVATIVES AS 5HT1-RECEPTOR AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1994-04-13 | — | — | EP | claimed |
| WO-1993000086-A1 | USE OF TETRAHYDROCARBAZONE DERIVATIVES AS 5HT1 RECEPTOR AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1993-01-07 | — | — | WO | claimed |
| WO-2012147020-A1 | AN IMPROVED PROCESS FOR THE PREPARATION OF FROVATRIPTAN | ORCHID CHEMICALS AND PHARAMCEUTICALS LIMITED (IN) | 2012-11-01 | — | — | WO | disclosed |
| WO-2010073253-A1 | METHOD FOR PREPARING AN OPTICALLY ACTIVE FROVATRIPTAN | NATCO PHARMA LIMITED (IN) | 2010-07-01 | — | — | WO | disclosed |
| EP-0674621-B1 | ENANTIOMERS OF CARBAZOLE DERIVATIVES AS 5-HT1-LIKE AGONISTS | VERNALIS LTD (GB) | 2003-02-26 | — | — | EP | disclosed |
| WO-2002094243-A1 | DELIVERY OF SUMATRIPTAN, FROVATRIPTAN OR NARATRIPTAN THROUGH AN INHALATION ROUTE | ALEXZA MOLECULAR DELIVERY CORPORATION (US) | 2002-11-28 | — | — | WO | disclosed |
| EP-1104292-A2 | TREATMENT OF VASODILATORY HEADACHE | Vernalis Limited (GB) | 2001-06-06 | — | — | EP | disclosed |
| WO-2000009099-A2 | TREATMENT OF VASODILATORY HEADACHE | VERNALIS LIMITED (GB) | 2000-02-24 | — | — | WO | disclosed |
| US-5616603-A | TREATING MIGRAINES | SMITHKLINE BEECHAM PLC (GB) | 1997-04-01 | — | — | US | disclosed |
| EP-0674621-A1 | ENANTIOMERS OF CARBAZOLE DERIVATIVES AS 5-HT1-LIKE AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1995-10-04 | — | — | EP | disclosed |
| WO-1994014772-A1 | ENANTIOMERS OF CARBAZOLE DERIVATIVES AS 5-HT1-LIKE AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1994-07-07 | — | — | WO | disclosed |
| EP-0591280-A1 | USE OF TETRAHYDROCARBAZOLE DERIVATIVES AS 5HT1-RECEPTOR AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1994-04-13 | — | — | EP | disclosed |
| WO-1993000086-A1 | USE OF TETRAHYDROCARBAZONE DERIVATIVES AS 5HT1 RECEPTOR AGONISTS | SMITHKLINE BEECHAM PLC (GB) | 1993-01-07 | — | — | WO | disclosed |